Ruzanna Isakhanyan is facing the most difficult challenge of her life. A few months ago, she was diagnosed with hormone receptor-positive, HER2-negative metastatic breast cancer.

Her only treatment option is a modern targeted therapy — Letrozole + Ribociclib — which can slow the progression of the disease and extend her life. However, the medication is extremely expensive, costing 800,000 AMD per month, and the treatment may last up to two years. Sadly, this medication is not covered by public healthcare programs and is financially out of reach for Ruzanna and her family.

Ruzanna has already endured many hardships — forced displacement, emotional trauma, and personal loss.
Today, she is simply fighting to stay alive, and only we can help her overcome the illness.

Every contribution, big or small, truly matters and can help save her life.